Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...

About 1 million Americans suffer from Parkinson's disease, with around 90,000 new cases diagnosed each year, according to the ...

The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.

After three years of study, the researchers found that alpha-synuclein, a protein closely linked to Parkinson’s disease, forms an abnormal connection with an enzyme called ClpP. This enzyme normally ...

Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical ...

Abnormal clumps of proteins like α-synuclein, amyloid beta and tau are associated with neurodegenerative conditions like ...

It’s the fastest-growing neurological disease in the world, and cases of Parkinson’s disease are only tipped to rise further ...

Both his neurologist and primary care physician have assured him he does not have Parkinson's or LBD, but are they correct?

Case Western Reserve researchers have found a unique biochemical route that plays a role in Parkinson's disease.

Controlling symptoms and maintaining mobility is currently the hallmark of managing patients with Parkinson's disease.

About 1 million Americans suffer from Parkinson's disease, with around 90,000 new cases diagnosed each year, according to the ...

FDA fast-tracks novel Parkinson’s cell therapy NouvNeu001, advancing treatment for dopaminergic neuron loss and motor ...